Vassalotti Joseph A, Francis Anna, Santos Augusto Cesar Soares Dos, Correa-Rotter Ricardo, Abdellatif Dina, Hsiao Li-Li, Roumeliotis Stefanos, Haris Agnes, Kumaraswami Latha A, Lui Siu-Fai, Balducci Alessandro, Liakopoulos Vassilios
Department of Medicine-Renal Medicine, Mount Sinai Hospital, New York, NY, USA.
National Kidney Foundation, Inc., New York, NY, USA.
Kidney Res Clin Pract. 2025 Jun 30. doi: 10.23876/j.krcp.25.106.
Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask "Are your kidneys ok?" using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes mellitus and measurement of blood pressure and body mass index. This World Kidney Day, we assert that case-finding in high-risk populations, or even population-level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for, and recent paradigm-shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure, and healthcare-professional and population awareness of kidney disease. Coordinated efforts by major kidney non-governmental organizations to prioritize the kidney health agenda for governments and to align early detection efforts with other current programs will maximize efficiencies.
早期识别肾脏疾病可保护肾脏健康,预防肾脏疾病进展及相关并发症,降低心血管疾病风险,并降低死亡率。我们必须通过检测血清肌酐以评估肾功能、检测尿白蛋白以评估肾脏及内皮损伤,来询问“你的肾脏还好吗?”。对慢性肾脏病(CKD)病因及风险因素的评估包括检测糖尿病、测量血压和体重指数。在今年的世界肾脏日,我们断言,在高危人群中开展病例发现工作,甚至进行全人群筛查,可减轻全球肾脏疾病负担。早期CKD没有症状,检测简单,而且近期如钠-葡萄糖协同转运蛋白2抑制剂等改变CKD治疗模式的疗法显著改善了治疗效果,有利于筛查或病例发现项目的成本效益分析。尽管如此,仍存在诸多障碍,包括资源分配、医疗保健资金、医疗基础设施以及医疗专业人员和公众对肾脏疾病的认知。主要肾脏非政府组织应协同努力,将肾脏健康议程列为政府工作重点,并使早期检测工作与其他现有项目保持一致,以实现效率最大化。